Thanks to the first endorphin stimulator combined with a digital service platform.
1.5 billion people worldwide suffer from chronic pain such as fibromyalgia, endometriosis, migraines and osteoarthritis and over half of them are not satisfied with their care.
Remedee Labs aims to change people’s lives thanks to the first endorphin stimulator combined with a patient-centered digital service platform.
“Drugs alone are often not enough to ease the burden for patients with chronic pain; holistic care, and combining several approaches, is essential. Remedee Labs Platform addresses this need and enables improvements to the patient’s care pathway”
Head of the Pain and Palliative Medicine Department at AP-HP and founding Chairman of Douleur Sans Frontière.
At Remedee Labs, we believe that our technology, no matter how innovative, can only be fully effective if it is part of a holistic care approach, tailored to individual needs and delivered by a dedicated team.
Remedee Labs’ Platform will offer a comprehensive and personalized experience with a multidisciplinary care designed for both patients and practitioners. It will enable remote support by care teams, coaches, practitioners and more, and includes personalized digital services available 24/7.
The Remedee Labs endorphin-stimulation solution is being tested in multiple clinical trials in European hospitals and research centers
